The incidence of EGFR-erbB2 interaction is also implicated as a prognostic parameter for high malignancy and drug resistance of breast cancer cells, and it is also associated with the occurrence of Y845 phosphorylation [79]. Here, ERBB2 is linked to breast carcinoma.